Fortis Healthcare Ltd. (FORTIS) 52 Week Low Streak: Why the Decline Is Sticking
- October 1, 2026
- Posted by: Chaitanya Auti
- Category: News
Fortis Healthcare Ltd. has now traded within 2% of its 52-week low for its second straight session, with the stock moving down 1.86% across the streak. At 11:22 AM IST, it was trading at Rs 722.15 after touching a low of Rs 711 during the session. The latest Univest data confirms the repeated near-low pattern, but it does not establish a company-specific cause for the continued decline.
The previous close was Rs 728, while the stock opened at Rs 728 and touched a high of Rs 728 before slipping lower. With a market capitalisation of Rs 55,553.6 crore, Fortis Healthcare remains a sizeable healthcare name, but the repeated near-one-year-low pattern matters more than a single-day move because it shows persistence rather than an isolated dip. For readers tracking Fortis Healthcare Ltd. share price action, the focus is on whether this weakness continues or begins to stabilise.
Fortis Healthcare Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 722.15 |
| Previous Close | Rs 728 |
| Today's Move | Rs -5.85 (-0.8%) |
| Open | Rs 728 |
| High | Rs 728 |
| Low | Rs 711 |
| Market Capitalisation | Rs 55,553.6 crore |
Fortis Healthcare Ltd. (FORTIS) traded at Rs 722.15 versus the previous close of Rs 728, a fall of 0.8%. The stock opened at Rs 728, reached a high of Rs 728, touched a low of Rs 711.
Fortis Healthcare Ltd. share price is trading at Rs 722.15, which is Rs 5.85 below the previous close of Rs 728, or down 0.8% at the time of writing. The stock opened at Rs 728 and also touched the same level as its intraday high, which means the early trade did not hold before the price moved lower later in the morning. The intraday low of Rs 711 shows the stock is still trading close to its yearly low zone.
For anyone following Fortis Healthcare Ltd. (FORTIS), the key point is not just the day move but the broader context of the Fortis 52 Week Low Streak. A single weak print can be noisy, while back-to-back sessions near the same low band indicate that the stock is remaining under pressure over multiple sessions. The market capitalisation of Rs 55,553.6 crore places the company among larger listed healthcare names, but size alone does not offset the current weakness in the share price. The pattern is also relevant for searchers looking for Fortis share price today, Fortis stock news and Fortis stock performance, because it reflects repeated downside rather than a one-off decline.
What the Repeated 52-Week Lows Show
The Fortis 52 Week Low Streak shows that the stock has stayed near its one-year trough for two consecutive sessions, which is the main story investors need to track. The cumulative decline of 1.86% across the streak is modest in percentage terms, but the repetition matters because it indicates that the weakness has not been confined to a single intraday move. For event-driven readers searching for Fortis consecutive 52 week low or Fortis back to back 52 week lows, the message is simple: the stock remains close to its lower boundary rather than moving away from it.
What the latest Univest data does not show is a confirmed company-specific trigger. That distinction is important. Fortis Healthcare Ltd. share price is still near the yearly low area, but the available numbers alone do not explain why. In practical terms, the pattern tells readers that the market is continuing to value the stock cautiously in the near term, even as the broader healthcare theme remains active on screens such as stocks hitting 52 week lows and stocks at one year low today.
Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 55,553.6 crore |
| P/E Ratio | 52.45x |
| P/B Ratio | 5.41x |
| ROE | 11.32% |
| ROCE | 14.07% |
| EPS | Rs 13.88 |
| Book Value Per Share | Rs 134.61 |
| Dividend Yield | 0.14% |
Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 52.45x, P/B 5.41x, ROE 11.32%, ROCE 14.07%. These figures provide context only and are not a buy or sell signal.
Fortis Healthcare Ltd. has a market capitalisation of Rs 55,553.6 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 52.45x, P/B at 5.41x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.84x, median ROE of 13.07%, median ROCE of 15.83%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 52.45x |
| Benchmark Median P/E | 31.84x |
| Benchmark Average P/E | 80.36x |
| Benchmark P/E Range | 0x to 1,528.53x |
| Company P/B Ratio | 5.41x |
| Benchmark Median P/B | 3.57x |
| Company ROE | 11.32% |
| Benchmark Median ROE | 13.07% |
| Company ROCE | 14.07% |
| Benchmark Median ROCE | 15.83% |
| Company Market Capitalisation | Rs 55,553.6 crore |
| Benchmark Median Market Cap | Rs 505.79 crore |
Fortis Healthcare Ltd. (FORTIS) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 52.45x, which is above the benchmark median of 31.84x, a difference of +64.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.07%, a difference of -13.39%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.83%, a difference of -11.12%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Aster DM Healthcare Ltd. | ASTERDM | 58,157.99 | 177.79 | 13.4 | 13.07 | 16.22 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 80,716.62 | 54.78 | 7.3 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 82,855.61 | 92.4 | 4.97 | 12.95 | 13.93 |
| Narayana Hrudayalaya Ltd. | NH | 35,602.72 | 43.21 | 7.43 | 19.86 | 16.2 |
| Global Health Ltd. | MEDANTA | 33,277.29 | 59.59 | 8.06 | 15.12 | 19.38 |
Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 52.45x compared with the displayed peer median of 59.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 55,553.6 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching
- Fortis Healthcare Ltd. has stayed near its 52-week low for a second straight session, which keeps the Fortis 52 Week Low Streak in focus.
- The cumulative move across the streak is down 1.86%, showing that the weakness has persisted beyond a single trading day.
- At Rs 722.15, the stock is still trading close to the lower end of its recent range, with an intraday low of Rs 711.
- The valuation remains above the same-industry median on both P/E and P/B, so the current share price does not look cheap on those measures.
- The latest data confirms the price pattern, but it does not identify a company-specific reason for the repeated near-low trade.
About the Company
Fortis Healthcare Ltd. is a listed healthcare company operating in the Hospital & Healthcare Services industry under the Healthcare sector. The business is followed closely by investors who track Fortis share price movements, Fortis NSE and BSE performance, and broader hospital-sector trends. With a market capitalisation of Rs 55,553.6 crore, the company is one of the larger names in the peer set used in this review.
Its current financial ratios place it in a valuation zone that is not inexpensive relative to the industry median, while its return ratios remain meaningful but not leading. That makes Fortis stock performance sensitive to both operating updates and wider sentiment toward healthcare names. For readers looking at Fortis company news, the present focus is the repeated near-52-week-low pattern rather than a fresh company-specific development.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Fortis still near its 52-week low?
Ans. Fortis has traded within 2% of its 52-week low for a second straight session, which shows continued weakness. The latest Univest data confirms the pattern, but it does not establish a company-specific cause for the move.
What was Fortis trading at during the latest update?
Ans. At 11:22 AM IST, Fortis was trading at Rs 722.15. The stock had a previous close of Rs 728, opened at Rs 728 and touched a low of Rs 711 during the session.
Is Fortis expensive compared with healthcare peers?
Ans. On the latest Univest peer data, Fortis trades above the same-industry median on both P/E and P/B. That means the stock is not priced cheaply relative to the group, even while it remains near a one-year low.
How does Fortis compare on returns such as ROE and ROCE?
Ans. Fortis has ROE of 11.32% and ROCE of 14.07%. These figures are below the peer medians in the healthcare set, so the stock does not stand out on return ratios at this point.
What does the market capitalisation tell investors?
Ans. Market capitalisation shows company size, not quality. Fortis’ market cap of Rs 55,553.6 crore indicates a large listed healthcare company, but it does not by itself explain the repeated near-low trading pattern.
What should investors monitor next in Fortis share price?
Ans. Investors should monitor whether the stock continues to trade near its yearly low or moves away from that zone. They should also watch earnings, valuation comparisons and any company-specific updates that may affect Fortis stock news.
Track Fortis Healthcare Ltd. (FORTIS) Share Price on Univest
Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.